{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T03:21:05Z","timestamp":1778988065199,"version":"3.51.4"},"reference-count":29,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2018,11,12]],"date-time":"2018-11-12T00:00:00Z","timestamp":1541980800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","award":["R14026FF"],"award-info":[{"award-number":["R14026FF"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","award":["PLBIO15\u2010256"],"award-info":[{"award-number":["PLBIO15\u2010256"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Cytometry Part B Clinical"],"published-print":{"date-parts":[[2019,5]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Mutiple myeloma (MM) is a neoplasia characterized by the accumulation of malignant plasma cells (PC) in the bone marrow. Although proliferation markers have been studied in MM, none of the current staging systems include them. Moreover, approaches used to analyze proliferation do not separate MM cells (MMCs) from normal PC.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this study, we combined multiparameter flow cytometry and BrdU incorporation or Ki67 staining to analyze MM cell proliferation in 44 monoclonal gammopathy of undetermined significance (MGUS), 153 newly diagnosed MM patients and 69 MM patients at relapse. The prognostic value of proliferation assessment was analyzed in 60 newly diagnosed patients treated with high\u2010dose chemotherapy supported by autologous hematopoietic stem cell transplantation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The median number of proliferating malignant PC significantly increases during MM disease progression. MM patients with a percentage of proliferating MMCs greater than 1.42% using BrdU\/DAPI or greater than 1.1% using ki67\/DAPI, are associated with a <jats:italic>significantly<\/jats:italic> shorter event free survival compared with patients with a lower percentage of proliferating MMCs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Combination of flow cytometry with BrdU or ki67\/DAPI staining could become a standard for the determination of MM cell proliferation. Furthermore, in the context of new effective myeloma treatment options, assessment of MM cell proliferation may be valuable, in clinical trials, to identify novel agents that could significantly affect the small proliferative compartment of MM cells. \u00a9 2018 International Clinical Cytometry Society.<\/jats:p><\/jats:sec>","DOI":"10.1002\/cyto.b.21730","type":"journal-article","created":{"date-parts":[[2018,11,12]],"date-time":"2018-11-12T08:41:28Z","timestamp":1542012088000},"page":"209-214","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["BrdU incorporation in multiparameter flow cytometry: A new cell cycle assessment approach in multiple myeloma"],"prefix":"10.1002","volume":"96","author":[{"given":"Guilhem","family":"Requirand","sequence":"first","affiliation":[{"name":"CHU Montpellier, Department of Biological Hematology  Montpellier France"},{"name":"IGH, CNRS, University of Montpellier  Montpellier France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Robert","sequence":"additional","affiliation":[{"name":"CHU Montpellier, Department of Biological Hematology  Montpellier France"},{"name":"IGH, CNRS, University of Montpellier  Montpellier France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phanie","family":"Boireau","sequence":"additional","affiliation":[{"name":"CHU Montpellier, Department of Biological Hematology  Montpellier France"},{"name":"IGH, CNRS, University of Montpellier  Montpellier France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laure","family":"Vincent","sequence":"additional","affiliation":[{"name":"CHU Montpellier, Department of Clinical Hematology  Montpellier France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja","family":"Seckinger","sequence":"additional","affiliation":[{"name":"Medizinische Klinik und Poliklinik V Universit\u00e4tsklinikum Heidelberg  Heidelberg Germany"},{"name":"Nationales Centrum f\u00fcr Tumorerkrankungen  Heidelberg Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salaheddine","family":"Bouhya","sequence":"additional","affiliation":[{"name":"CHU Montpellier, Department of Clinical Hematology  Montpellier France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrice","family":"Ceballos","sequence":"additional","affiliation":[{"name":"CHU Montpellier, Department of Clinical Hematology  Montpellier France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillaume","family":"Cartron","sequence":"additional","affiliation":[{"name":"CHU Montpellier, Department of Clinical Hematology  Montpellier France"},{"name":"University of Montpellier, UFR de M\u00e9decine  Montpellier France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk","family":"Hose","sequence":"additional","affiliation":[{"name":"Medizinische Klinik und Poliklinik V Universit\u00e4tsklinikum Heidelberg  Heidelberg Germany"},{"name":"Nationales Centrum f\u00fcr Tumorerkrankungen  Heidelberg Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Klein","sequence":"additional","affiliation":[{"name":"CHU Montpellier, Department of Biological Hematology  Montpellier France"},{"name":"IGH, CNRS, University of Montpellier  Montpellier France"},{"name":"University of Montpellier, UFR de M\u00e9decine  Montpellier France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5717-3207","authenticated-orcid":false,"given":"J\u00e9r\u00f4me","family":"Moreaux","sequence":"additional","affiliation":[{"name":"CHU Montpellier, Department of Biological Hematology  Montpellier France"},{"name":"IGH, CNRS, University of Montpellier  Montpellier France"},{"name":"University of Montpellier, UFR de M\u00e9decine  Montpellier France"},{"name":"UMR CNRS 5235 University of Montpellier  Montpellier France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2018,11,12]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60221-X"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2011.63"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.21273"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.20512"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.46.2119"},{"key":"e_1_2_7_7_1","first-page":"111","article-title":"Potential pitfalls of [3H]thymidine techniques to measure cell proliferation","volume":"14","author":"Maurer HR","year":"1981","journal-title":"Cell Tissue Kinet"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-4827(85)90549-X"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1988.tb02368.x"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.2.448.448"},{"key":"e_1_2_7_11_1","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1182\/blood.V72.1.219.219","article-title":"Value of beta 2\u2010microglobulin level and plasma cell labeling indices as prognostic factors in patients with newly diagnosed myeloma","volume":"72","author":"Greipp PR","year":"1988","journal-title":"Blood"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-03-341933"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.coc.0000045810.91816.41"},{"key":"e_1_2_7_14_1","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/cyto.b.21590","article-title":"Automated and simplified identification of normal and abnormal plasma cells in Multiple Myeloma by flow cytometry","volume":"94","author":"Alaterre E","year":"2017","journal-title":"Cytometry B Clin Cytom"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-09-178350"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1004077"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2004-5-10-r80"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0506580102"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-9473(02)00225-6"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-018-0025-x"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2011.046821"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.54"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-11-013458"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2010.030296"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-07-038430"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btt124"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.13.8545"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.07.1209"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcb.2009.06.005"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1098\/rsfs.2013.0074"}],"container-title":["Cytometry Part B: Clinical Cytometry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcyto.b.21730","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cyto.b.21730","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/cyto.b.21730","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cyto.b.21730","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,10]],"date-time":"2023-09-10T17:36:18Z","timestamp":1694367378000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/cyto.b.21730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,12]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["10.1002\/cyto.b.21730"],"URL":"https:\/\/doi.org\/10.1002\/cyto.b.21730","archive":["Portico"],"relation":{},"ISSN":["1552-4949","1552-4957"],"issn-type":[{"value":"1552-4949","type":"print"},{"value":"1552-4957","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,12]]},"assertion":[{"value":"2018-04-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-07-27","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-11-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}